Description
+ Include: 37 videos + 1 pdf, size: 19.3 GB
+ Target Audience: hematologist, oncologist
+ Sample video: contact me for sample video
+ Information:
The European Hematology Association (EHA) and the EBMT are excited to announce the 4th edition of the jointly organized European CAR T-cell Meeting. This meeting will be fully virtual.
Dates: February 10-12, 2022
Chairs: Michael Hudecek & Ibrahim Yakoub-Agha
Format: Virtual
The meeting will cover a broad range of topics including deep science and translational, clinical and commercial development in the field of CAR T. The programme will bring you all the latest in CAR T and will even bring in the first ever reported clinical data.
Join the meeting to be able to hear the latest developments and to have the chance to discuss this important topic with both experts and your peers.
Target Audience
The target audience is hematologists, oncologists, physicians, nurses, data managers, supply chain managers, patient organization representatives, patients, biothech representatives, industry representatives, pharmacists and manufacturers.
+ Topics:
pdf-program.pdf
BA01 – Best abstracts & Awards.mp4
BA02 – Best abstracts flash talks.mp4
BA03 – Best abstracts flash talks.mp4
CLS – Closing remarks.mp4
IT02 – Industry Theatre (Auditorium 1) The Future of CART by Novartis.mp4
IT03 – Industry Theatre (Auditorium 1) Kite as innovators in CAR T-cell therapy manufacturing and delivery.mp4
KN01 – Keynote Lecture 1.mp4
KN02 – Keynote Lecture 2.mp4
KN03 – Panel Chairs & Keynote Lecture 3.mp4
KN04 – Keynote Lecture 4.mp4
NG01 – Nurses Session I – Overview.mp4
NG02 – Nurses Session II – Treatment Updates.mp4
NG03 – Nurses Session III – Patient Experience.mp4
NG04 – Nurses Session IV – Treatment outcome influencers.mp4
OP01 – Opening.mp4
OPN1 – Introduction & Welcome + NG00 – The Nice Experience.mp4
PA01 – Things you need to know about CAR T-cell therapy talking about CAR-T cell therapy in lay.mp4
PS01 – Session 1 – Clinical Indications.mp4
PS02 – Session 2 – New Clinical Data and Trial Pipeline.mp4
PS03 – Session 3 – Next-Gen CAR-T Therapy.mp4
PS04 – Session 4 – CAR-T in Oncology.mp4
PS05 – Session 5 – Interactive pros cons.mp4
PS06 – Session 6 – New CAR-T Indications.mp4
PS07 – Session 7 – CAR-T New Standard of Care in Lymphoma.mp4
PS08 – Session 08 – Clinical management.mp4
PS09 – Session 09 – CAR T Technology Forum.mp4
PS10 – Session 10 – How to set-up and run a CAR-T unit.mp4
PS11 – Session 11 – Biotech Forum.mp4
PS12 – Session 12 – Trial management.mp4
PT01 – Virtual Poster Tour 1 Pre-clinical Data.mp4
PT02 – Virtual Poster Tour 2 Clinical data.mp4
PT03 – Virtual Poster Tour 3 Pre-clinical Data.mp4
PT04 – Virtual Poster Tour 4 Clinical Data.mp4
SS01 – Satellite symposium by Janssen Transforming the landscape of multiple myeloma with CAR T-cell therapies.mp4
SS02 – Satellite symposium by Bristol Myers Squibb CAR T cell therapy current status and new.mp4
SS04 – Satellite Symposium by Gilead Kite on R R DLBCL highlights in CAR T from ASH 2021.mp4
YA01 – EBMT Trainee Committee & YoungEHA Ambassadors.mp4
Reviews
There are no reviews yet.